3509 results for «2029»
3509 results
TAVI and future coronary access - LIVE case
18 Feb 2024 – From PCR Tokyo Valves 2024
An 81-year-old woman, with a history of breast cancer surgery, stroke, and lymphoma remission, presented a severe symptomatic aortic stenosis associated with a suspicion of right coronary artery disease on the CT. The operators decided to perform TAVI first and then control the RCA by angiography...

PCR Tokyo Valves 2024 Closing Ceremony
18 Feb 2024 – From PCR Tokyo Valves 2024
The closing ceremony of this 2024 edition of PCR Tokyo Valves is an opportunity to present the finalists and then to award the prizes to the winners of the best clinical case and best scientific abstract, before thanking all those involved in making the 3-day Course...

TAV-in-TAV interventions: a new frontier in TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore the distinctions between TAV-in-TAV and TAV-in-SAV, learn more about the challenges posed by heterogeneity and variability in TAV redo procedures, gain insights into the unified terminology of TAV designs, and uncover how step-by-step CT analysis facilitates comprehensive assessments and post Redo-TAV solutions, drawing from detailed...

Heart Team in action: managing complex cases together
17 Feb 2024 – From PCR Tokyo Valves 2024
In this group discussion, several heart teams present their work on complex cases of tricuspid valve interventions and explore the results of their collaboration in order to figure out adequate management for invasive treatments.

Learn the evidence - Lifetime management of aortic stenosis therapy with self-expandable valve
17 Feb 2024 – From PCR Tokyo Valves 2024
In this dedicated session on aortic stenosis management, gain insights into interpreting the 10-year outcomes of the NOTION trial, the 4-year outcomes of the Evolut Low Risk trial, and the key findings from the CANNULATE TAVR study, and discuss the issue of long-term device durability, draw comparisons...

Plan your moves: strategies for valves re-intervention
17 Feb 2024 – From PCR Tokyo Valves 2024
This special session sponsored by Edwards Lifesciences focuses on recognising key elements of valve design that impact ability to host future valves re-interventions, learning how to achieve repeatable implant experiences for the index valve and second valve, and identifying strategies to simplify transcatheter heart valve redo...

New possibilities in TEER
18 Feb 2024 – From PCR Tokyo Valves 2024
Watch this session to get an overview of a new TEER device, follow the step-by-step procedure related to initial experiences with this device for a Japanese patient with degenerative mitral regurgitation, learn about the latest data from RCT and registries, and follow discussions of challenging TEER...

PCI after TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
Through these slides, examine selected cases of percutaneous coronary intervention after TAVI. Explore the case of a successful bailout PCI with en-face view for sinus sequestration after self-expandable TAVI, learn about best management of previous implanted chimney stent during TAVI, and more.

Rapid-fire - LAA closure and plugging
17 Feb 2024 – From PCR Tokyo Valves 2024
In this series of rapid-fire case submissions, explore cases of left atrium appendage closure and plugging. Discover compelling cases such as the transcatheter closure of a very late atrial septal defect device erosion, learn about the importance of transseptal puncture during left appendage closure, and more....

The role of WATCHMAN therapy in optimising results and future perspectives
17 Feb 2024 – From PCR Tokyo Valves 2024
This special session sponsored by Boston Scientific will help you understand the latest status and the value of WATCHMAN therapy, as well as learning about future perspectives of LAA closure by new WATCHMAN FLX pro.

Essentials of lifetime management of TAVI patients
20 Nov 2023 – From PCR London Valves 2023
In this session, discover the key features and benefits of next-generation transcatheter heart valve technology. Gain insights into managing bicuspid and valve-in-valve interventions, and understand the procedural and clinical significance of intermediate and XL sizes in addressing unmet clinical needs.

Expert roundtable: 4D ICE in tricuspid interventions
20 Nov 2023 – From PCR London Valves 2023
Join this session if you want to get familiar with the 4D ICE technology and the key elements of image guidance for tricuspid interventions, understand how 4D ICE can assist in specific procedural steps during challenging tricuspid interventions, and engage in an interactive discussion with experts...

Advancing valve repair: mastering diverse mitral and tricuspid regurgitation anatomies with the PASCAL Precision system
20 Nov 2023 – From PCR London Valves 2023
Participate in this session to stay informed about the latest clinical and real-world evidence for mitral and tricuspid TEER using PASCAL. Explore case-based discussions on mitral regurgitation treatment using PASCAL Precision, and actively participate in an educational tricuspid TEER recorded case procedure featuring the PASCAL Precision.

Defying complexity: achieving optimal TAVI procedural outcomes in challenging anatomies with the new Evolut FX
20 Nov 2023 – From PCR London Valves 2023
Watch this session to understand factors to consider when deciding on valve selection, recognize the significance of device choice and implantation technique in redo-TAVI, and acquire insights into anticipating challenges associated with implanting a bicuspid valve, large anatomy, and a horizontal aorta.

TAVI unleashed: optimisation of immediate and long-term outcomes
20 Nov 2023 – From PCR London Valves 2023
Consult this session if you want to gain insights into the effects of paravalvular leak, conduction disturbances, stroke, and permanent pacemaker issues following transcatheter aortic valve implantation. The discussion also delves into the design of transcatheter heart valves and its implications for selecting the initial valve...

Tricuspid transcatheter valve replacement: Cardiovalve keeps things in motion
20 Nov 2023 – From PCR London Valves 2023
Participate in this session to stay informed about the latest advancements in TTVR, receive updates on the Cardiovalve tricuspid program, and gain insights into how imaging demonstrates the concept underlying Cardiovalve transcatheter valve replacement technology.

TAVI failure - Mechanisms and management
19 Nov 2023 – From PCR London Valves 2023
Explore various cases that focus on TAVI failure, including the effects of the mechanism of TAVR failure on outcomes after re-intervention, the prognostic impact of patient-prosthesis mismatch and paravalvular leak following TAVI, issues related to bioprosthetic valve dysfunction and much more!

Essentials of lifetime management of TAVI patients
21 Nov 2023 – From PCR London Valves 2023
Consult this session if you want to learn about the next generation transcatheter heart valve technology key features, procedural and clinical benefits, to learn tips and tricks for managing bicuspid and valve-in-valve interventions, and to understand procedural and clinical relevance of intermediate and XL sizes in...

Prevention and treatment of left ventricular outflow tract obstruction
19 Nov 2023 – From PCR London Valves 2023
Explore intriguing cases in this session and gain a deeper understanding of preventing and managing LVOT obstruction: uncover innovative approaches such as Valve-in-Valve TMVR with Lampoon, learn about the nuances of TMVR after re-section of the anterior leaflet, and more!

VitaFlow - The electrically enable self-expanding TAVI valve
21 Nov 2023 – From PCR London Valves 2023
This session provides insights into the unique design and advantages of VitaFlow Liberty for TAVI. It covers techniques to minimize microdislodgement during the procedure, identifies situations and patient types most suitable for VitaFlow Liberty, and reviews early clinical results associated with this technology.
